Commercial Due Diligence & Value Creation Strategy for a Private Equity Investment in Saudi Arabia's Healthcare Services Sector

A regional private equity firm with significant GCC investment experience, evaluating a majority stake acquisition in a Saudi Arabian private healthcare services platform — comprising a network of outpatient clinics, diagnostic centers, and day surgery facilities operating across multiple Saudi cities. The firm had identified the investment through Saudi Arabia's healthcare privatization pipeline and was conducting formal due diligence ahead of a binding offer submission with a transaction value in excess of SAR 800 million.

The private equity firm faced a set of due diligence, valuation, and value creation planning challenges requiring specialist Saudi healthcare market expertise and strategic advisory capability:

• Market Demand Validation: The target's management projections assumed aggressive revenue growth driven by Vision 2030's healthcare privatization and insurance expansion agenda. However, the firm required independent validation of whether the specific market segments, geographies, and service lines targeted by the platform's growth plan were genuinely supported by demonstrated demand or reflected optimistic assumptions that warranted valuation adjustments.
• Competitive Position Assessment: Saudi Arabia's private healthcare services sector was attracting significant investment and competitive entry from both domestic and international operators. This created uncertainty regarding the sustainability of the target's competitive position and its ability to defend market share against larger, better-capitalized competitors with stronger brands and clinical capabilities.
• Operational Quality & Scalability: The firm required an independent assessment of whether the target's operational model, including clinical protocols, staffing structures, technology infrastructure, supply chain management practices, and patient experience frameworks, was sufficiently robust to support the geographic expansion and revenue growth assumptions embedded within the acquisition investment thesis.
• Regulatory & Compliance Risk: Saudi Arabia's healthcare regulatory environment was evolving rapidly under Vision 2030's Health Sector Transformation Program. The firm needed clarity on potential compliance exposure, licensing risks, and the operational and financial implications of forthcoming regulatory changes affecting the target's business model.
• Saudization Compliance Position: The target's workforce profile was only marginally above existing Saudization compliance thresholds. The firm therefore required an assessment of whether future workforce nationalization requirements could create material cost pressures, talent shortages, or operational constraints that might affect long-term financial performance.
• Value Creation Roadmap: Beyond transaction completion, the firm required a structured 100-day plan and medium-term value creation roadmap identifying the operational, commercial, and strategic initiatives most likely to accelerate EBITDA growth and support valuation multiple expansion in line with the firm's targeted exit objectives.

Eurogroup Consulting was engaged to deliver integrated commercial due diligence and value creation strategy advisory — providing the firm with the independent market validation, competitive assessment, operational quality evaluation, regulatory risk analysis, and structured value creation roadmap needed to make a confident investment decision and execute a disciplined post-acquisition value creation program.

The engagement was executed across five integrated due diligence and value creation workstreams:

• Market & Demand Due Diligence: Conducted a granular analysis of the Saudi private healthcare outpatient and diagnostics market, including segmented demand forecasting by specialty, geography, and payer category; insurance coverage expansion trajectory analysis; competitor supply pipeline assessment; and validation of Vision 2030 healthcare privatization demand catalysts. This resulted in an independent assessment of market size and growth potential against which management projections could be evaluated.
• Competitive Position & Strategy Assessment: Evaluated the target's competitive position across each service line and geographic market, assessing clinical quality reputation, brand strength, patient loyalty, physician relationships, technology infrastructure, and digital health capabilities relative to current and emerging competitors. The assessment identified both sustainable competitive advantages and areas requiring strategic investment or repositioning.
• Operational Quality & Scalability Review: Conducted operational assessments across representative facilities, evaluating clinical protocols, patient flow management, staffing efficiency, supply chain performance, facility operations, and technology platform readiness against Saudi healthcare benchmarks and the operational requirements necessary to support the expansion strategy embedded in the acquisition business plan.
• Regulatory & Saudization Risk Assessment: Analyzed the target's compliance position across licensing, accreditation, insurance panel participation, and employment regulations. This included a forward-looking assessment of Saudization compliance under multiple regulatory scenarios and quantified financial modeling of the potential EBITDA impact associated with future workforce nationalization requirements.
• Value Creation Roadmap Development: Developed a structured 100-day post-acquisition plan and a three-year value creation roadmap, identifying and quantifying the commercial, operational, and strategic initiatives most likely to accelerate EBITDA growth and valuation multiple expansion. Initiatives were prioritized based on implementation timeline, capital requirements, execution risk, and expected financial impact.

Key advisory recommendations delivered through the engagement:

• Revised Valuation: Independent market demand analysis supported a 12% reduction in the firm's initial valuation assessment, reflecting more conservative market growth assumptions in two geographic markets where management projections were not supported by demonstrated demand evidence. This provided the foundation for a revised offer that improved the firm's entry multiple and projected IRR.
• Conditional Investment Recommendation: Recommended proceeding with the investment subject to three specific pre-closing conditions: resolution of an identified licensing compliance issue in one city, contractual commitment from management to a Saudization compliance acceleration plan, and renegotiation of two physician employment contracts that created significant key-person dependency risk.
• Geographic Expansion Reprioritization: Advised reprioritizing the target's geographic expansion strategy by deferring entry into two highly competitive markets with limited differentiation potential and accelerating expansion into an underserved market offering strong demand growth, limited competition, and favorable regulatory conditions likely to generate superior returns on expansion capital.
• Operational Improvement Priorities: Identified approximately SAR 42 million in near-term annual EBITDA improvement opportunities through revenue cycle optimization, supply chain procurement consolidation, clinical staffing model efficiency enhancements, and facility management cost reductions. These initiatives represented an estimated 28% improvement over the target's current EBITDA before any revenue growth was realized.
• Digital Health Investment: Recommended priority investment in a digital patient engagement platform and telemedicine capability, identified as both a patient experience differentiator and a cost-efficient capacity expansion mechanism aligned with Saudi Arabia's digital health agenda. The initiative was projected to generate an additional 18% revenue from existing patient relationships within 24 months of implementation.

The commercial due diligence and value creation advisory delivered material transaction and portfolio value:

• Valuation Adjustment: Independent demand analysis supported a SAR 96 million reduction in acquisition consideration, directly improving the firm's projected equity IRR by 2.1 percentage points compared to the original bid assumptions.
• Pre-Closing Risk Mitigation: Identification and resolution of a licensing compliance issue prior to closing prevented a regulatory non-compliance situation that could have resulted in facility operating license suspension and an estimated annual revenue impact of SAR 35 million if discovered post-acquisition.
• Post-Acquisition Performance: Implementation of the operational improvement program generated SAR 31 million in EBITDA improvements within the first 12 months following acquisition, exceeding the Year 1 target established in the value creation roadmap and validating the firm's investment thesis to its limited partners.
• Geographic Expansion ROI: Accelerated market entry into the underserved geography identified through the advisory process generated first-year revenue of SAR 58 million against a capital investment of SAR 85 million, tracking toward a projected three-year payback period aligned with the firm's return expectations.
• Exit Positioning: Twenty-four months post-acquisition, the platform's EBITDA growth trajectory, digital health capability development, and strengthened Saudization compliance position had significantly enhanced its strategic attractiveness to the three potential strategic acquirers identified in the value creation roadmap. This positioned the firm to pursue an exit at a target valuation multiple of 12–14x EBITDA compared with an entry multiple of 9.2x.